Several southern U.S. states reported sharp increases in COVID-19 infections, with Alabama, South Carolina and Virginia all seeing new cases rise 35% or more in the week ended May 31 compared with the prior week, according to a Reuters analysis.
South Carolina health officials said they expected more increases in the future due to a lack of social distancing and mask wearing at protests triggered by the death of George Floyd while in police custody in Minnesota.
Former U.S. President Obama condemns violence at protests
WASHINGTON - Former U.S. President Barack Obama on Monday condemned the use of violence at nationwide protests over racial inequities and excessive police force, while praising the actions of peaceful protesters seeking change.
The vast majority of protesters have been peaceful, but a "small minority" were putting people at risk and harming the very communities the protests are intended to help, Obama wrote in an online essay posted on Medium.
Protests elevate Bottoms and Demings as possible Biden running matesAtlanta Mayor Keisha Lance Bottoms and U.S. Representative Val Demings of Florida have risen in prominence amid protests against police brutality as Joe Biden weighs whether to choose a black woman as his Democratic running mate for November's presidential election.
Activists say such a pick would excite disenchanted African-American voters and demonstrate to a crucial part of the Democratic base that Biden is committed to criminal justice reform following the death of George Floyd, who was black, in Minneapolis last week at the hands of a white police officer.
Gilead's remdesivir shows modest improvement in moderate COVID-19 patientsGilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.
Gilead shares fell about 4%.
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials, and new information about its efficacy is being closely watched around the world, as nations battle the pandemic.